Effect of NUV001 Supplementation in Patients Suffering From Sickle Cell Disease (SCD)

NAActive, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

May 10, 2024

Study Completion Date

June 30, 2024

Conditions
Sickle Cell Disease
Interventions
DIETARY_SUPPLEMENT

NUV001

Daily supplementation with NUV001 at 1000 mg (4 tablets of 250 mg each) for 90 days with a prolonged follow-up of 1 month (30 days) after stopping the supplementation

Trial Locations (1)

13005

Aphm Hopital La Timone Adultes Sce Medecine Interne (Umap), Marseille

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CEN Biotech

INDUSTRY

collaborator

Assistance Publique Hopitaux De Marseille

OTHER

collaborator

Etablissement Français du Sang

OTHER

lead

LGD

INDUSTRY

NCT05789355 - Effect of NUV001 Supplementation in Patients Suffering From Sickle Cell Disease (SCD) | Biotech Hunter | Biotech Hunter